Search

everythinglearnresearchcommunity

for

Search:↓

Markers help differentiate between apocrine and eccrine sweat glands to identify sweat gland tumors.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

An isolated episcleral plasmacytoma can mimic episcleritis, making diagnosis challenging.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Sheep with chronic Sarcoptes scabiei dermatitis have altered keratin expression in their skin.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

Adding a second method to PROTACs could improve cancer treatment.

Cell detachment, not autoantibody binding, causes major changes in pemphigus.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Promising cancer treatments were found, but the manufacturer closed.

DNA virus-induced tumors have consistent isozyme profiles, unlike other tumor types.

The specific skin disease variant p.(Arg2000Trp) in plectin can cause a wide range of symptoms, which should be considered when diagnosing patients.

Basal-cell epitheliomas and the pilosebaceous tract share a unique keratin, distinguishing them from other skin areas.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Sex hormone antibodies can help identify male and female contributors in forensic samples.